과제정보
This study was supported by the 2022 Startup and Commercialization Support Project of the Ministry of SMEs and Startups (Project No. 20052267).
참고문헌
- Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer: A Cancer Journal for Clinicians. 2021;71(3):209-49. https://doi.org/10.3322/caac.21660
- Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer: A Cancer Journal for Clinicians. 2018;68(6):394-424. https://doi.org/10.3322/caac.21492
- National Cancer Registration Project statistics Report. National Cancer Information Center [serial online] 2023 Jan 5 [cited 2023 Jun 7]; 1(1):[2 screens]. Available from: URL: https://www.cancer.go.kr/lay1/S1T639C640/contents.do.
- Stark L, Tofthagen C, Visovsky C, McMillan SC. The symptom experience of patients with cancer. Journal of Hospice & Palliative Nursing. 2012;14(1):61-70. https://doi.org/10.1097/NJH.0b013e318236de5c
- Park SB, Yoon JH, Kim EH, Lee JY, Yoon SW. A review of studies using syndrome differentiation questionnaire in cancer patients. Journal of Korean Traditional Oncology. 2021;26(1):1-15.
- Anderson LJ, Albrecht ED, Garcia JM. Update on management of cancer-related cachexia. Current Oncology Reports. 2017;19(1):3.
- Barreto R, Mandili G, Witzmann FA, Novelli F, Zimmers TA, Bonetto A. Cancer and chemotherapy contribute to muscle loss by activating common signaling pathways. Frontiers in Physiology. 2016;7:472.
- Gilliam LA, St Clair DK. Chemotherapy-induced weakness and fatigue in skeletal muscle: the role of oxidative stress. Antioxidants & Redox Signaling. 2011;15(9):2543-63. https://doi.org/10.1089/ars.2011.3965
- Barreto R, Waning DL, Gao H, Liu Y, Zimmers TA, Bonetto A. Chemotherapy-related cachexia is associated with mitochondrial depletion and the activation of ERK1/2 and p38 MAPKs. Oncotarget. 2016;7(28):43442-60. https://doi.org/10.18632/oncotarget.9779
- Daly LE, Ni Bhuachalla EB, Power DG, Cushen SJ, James K, Ryan AM. Loss of skeletal muscle during systemic chemotherapy is prognostic of poor survival in patients with foregut cancer. Journal of Cachexia, Sarcopenia and Muscle. 2018;9(2):315-25. https://doi.org/10.1002/jcsm.12267
- Windholz T, Swanson T, Vanderbyl BL, Jagoe RT. The feasibility and acceptability of neuromuscular electrical stimulation to improve exercise performance in patients with advanced cancer: a pilot study. BMC Palliative Care. 2014;13(1):1-8. https://doi.org/10.1186/1472-684X-13-1
- Bax L, Staes F, Verhagen A. Does neuromuscular electrical stimulation strengthen the quadriceps femoris? A systematic review of randomised controlled trials. Sports Medicine. 2005;35(3):191-212.
- Feil S, Newell J, Minogue C, Paessler HH. The effectiveness of supplementing a standard rehabilitation program with superimposed neuromuscular electrical stimulation after anterior cruciate ligament reconstruction: a prospective, randomized, single-blind study. The American Journal of Sports Medicine. 2011;39(6):1238-47. https://doi.org/10.1177/0363546510396180
- Stevens JE, Mizner RL, Snyder-Mackler L. Neuromuscular electrical stimulation for quadriceps muscle strengthening after bilateral total knee arthroplasty: a case series. Journal of Orthopaedic & Sports Physical Therapy. 2004;34(1):21-9. https://doi.org/10.2519/jospt.2004.34.1.21
- Crevenna R, Marosi C, Schmidinger M, Fialka-Moser V. Neuromuscular electrical stimulation for a patient with metastatic lung cancer: a case report. Support Care Cancer. 2006;14(9):970-3. https://doi.org/10.1007/s00520-006-0033-x
- Kim SY, Park DA, Seo HJ, Shin SS, Lee SJ, Lee M, Park KI. Health technology assessment methodology: systematic review. National Evidence-based Healthcare Collaborating Agency. 2020:23-37.
- Jones S, Man WD, Gao W, Higginson IJ, Wilcock A, Maddocks M. Neuromuscular electrical stimulation for muscle weakness in adults with advanced disease. Cochrane Database of Systematic Reviews. 2016;10(10):CD009419.
- Higgins JP, Altman DG, Gotzsche PC, Juni P, Moher D, Oxman AD, Savovic J, Schulz KF, Weeks L, Sterne JA; Cochrane Bias Methods Group, Cochrane Statistical Methods Group. The cochrane collaboration's tool for assessing risk of bias in randomised trials. British Medical Journal. 2011;343(7829):d5928.
- Lavigne C, Twomey R, Lau H, Francis G, Culos-Reed SN, Millet GY. Feasibility of eccentric overloading and neuromuscular electrical stimulation to improve muscle strength and muscle mass after treatment for head and neck cancer. Journal of Cancer Survivorship. 2020;14(6):790-805. https://doi.org/10.1007/s11764-020-00893-9
- Maddocks M, Lewis M, Chauhan A, Manderson C, Hocknell J, Wilcock A. Randomized controlled pilot study of neuromuscular electrical stimulation of the quadriceps in patients with non-small cell lung cancer. Journal of Pain and Symptom Management. 2009;38(6):950-6. https://doi.org/10.1016/j.jpainsymman.2009.05.011
- Maddocks M, Halliday V, Chauhan A, Taylor V, Nelson A, Sampson C, Byrne A, Griffiths G, Wilcock A. Neuromuscular electrical stimulation of the quadriceps in patients with non-small cell lung cancer receiving palliative chemotherapy: a randomized phase II study. PLoS One. 2013;8(12):e86059.
- Toth MJ, Voigt TB, Tourville TW, Prior SM, Guigni BA, Schlosberg AV, Smith IB, Forest TJ, Kaufman PA, Wood ME, Rehman H, Dittus K. Effect of neuromuscular electrical stimulation on skeletal muscle size and function in patients with breast cancer receiving chemotherapy. Journal of Applied Physiology. 2020;128(6):1654-65. https://doi.org/10.1152/japplphysiol.00203.2020
- Fukushima H, Koga F. Impact of sarcopenia in the management of urological cancer patients. Expert Review of Anticancer Therapy. 2017;17(5):455-66. https://doi.org/10.1080/14737140.2017.1301209
- Kazemi-Bajestani SM, Mazurak VC, Baracos V. Computed tomography-defined muscle and fat wasting are associated with cancer clinical outcomes. Seminars in Cell & Developmental Biology. 2016;54:2-10. https://doi.org/10.1016/j.semcdb.2015.09.001
- Shachar SS, Williams GR, Muss HB, Nishijima TF. Prognostic value of sarcopenia in adults with solid tumours: a meta-analysis and systematic review. European Journal of Cancer. 2016;57:58-67. https://doi.org/10.1016/j.ejca.2015.12.030
- Gruber ES, Jomrich G, Tamandl D, Gnant M, Schindl M, Sahora K. Sarcopenia and sarcopenic obesity are independent adverse prognostic factors in resectable pancreatic ductal adenocarcinoma. PLoS One. 2019;14(5):e0215915.
- Rutten IJ, Ubachs J, Kruitwagen RF, van Dijk DP, Beets-Tan RG, Massuger LF, Olde Damink SW, Van Gorp T. The influence of sarcopenia on survival and surgical complications in ovarian cancer patients undergoing primary debulking surgery. European Journal of Surgical Oncology. 2017;43(4):717-24. https://doi.org/10.1016/j.ejso.2016.12.016
- Anjanappa M, Corden M, Green A, Roberts D, Hoskin P, McWilliam A, Choudhury A. Sarcopenia in cancer: risking more than muscle loss. Technical Innovations & Patient Support in Radiation Oncology. 2020;16:50-7. https://doi.org/10.1016/j.tipsro.2020.10.001